Evommune, Inc.
EVMN
$18.41
-$1.82-9.00%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 3.00M | 0.00 | 0.00 | 0.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 3.00M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | 3.00M | 0.00 | 0.00 | 0.00 |
| SG&A Expenses | 3.36M | 3.67M | 3.43M | 3.43M | 3.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.99M | 18.03M | 18.99M | 18.99M | 28.29M |
| Operating Income | -22.99M | -15.03M | -18.99M | -18.99M | -28.29M |
| Income Before Tax | -13.57M | -14.56M | -18.32M | -18.32M | -27.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.57M | -14.56M | -18.32M | -18.32M | -27.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.57M | -14.56M | -18.32M | -18.32M | -27.38M |
| EBIT | -22.99M | -15.03M | -18.99M | -18.99M | -28.29M |
| EBITDA | -22.62M | -14.66M | -18.64M | -18.64M | -27.96M |
| EPS Basic | -1.02 | -1.11 | -1.47 | -1.47 | -18.35 |
| Normalized Basic EPS | -0.64 | -0.70 | -0.88 | -0.88 | -11.47 |
| EPS Diluted | -1.02 | -1.11 | -1.47 | -1.47 | -18.35 |
| Normalized Diluted EPS | -0.64 | -0.70 | -0.88 | -0.88 | -11.47 |
| Average Basic Shares Outstanding | 13.25M | 13.07M | 12.99M | 12.99M | 1.49M |
| Average Diluted Shares Outstanding | 13.25M | 13.07M | 12.99M | 12.99M | 1.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |